October 21 - 24, 2008
Geneva Palexpo
Geneva, Switzerland
This symposium, hosted by EORTC, NCI and AACR, brought together academics and scientists and representatives from the pharmaceutical industry to discuss innovations in drug development, target selection, and the impact of new discoveries in molecular and cell biology. Understanding the pathways and mechanisms which cause cancer and regulate the biological behavior of tumor cells has lead to the development of numerous new agents and innovative targets for clinical trials. This conference was organized to reflect the many recent advances in the early development of promising new compounds, which are in different levels of preclinical and clinical development. Delegates from all over the world joined together in Geneva to ignite a huge exchange of information and develop new global partnerships in translational research.
For additional information about the 2008 Symposium, please visit the European CanCer Organization website or contact:
ECCO - the European CanCer Organisation
Avenue E. Mounier 83
B-1200 Brussels
Belgium
Tel: +32 (2) 775-0201